These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9708558)

  • 1. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.
    Reiman EM; Uecker A; Caselli RJ; Lewis S; Bandy D; de Leon MJ; De Santi S; Convit A; Osborne D; Weaver A; Thibodeau SN
    Ann Neurol; 1998 Aug; 44(2):288-91. PubMed ID: 9708558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
    Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
    Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Alzheimer disease risk by functional magnetic resonance imaging.
    Fleisher AS; Houston WS; Eyler LT; Frye S; Jenkins C; Thal LJ; Bondi MW
    Arch Neurol; 2005 Dec; 62(12):1881-8. PubMed ID: 16344346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
    Caselli RJ; Reiman EM; Hentz JG; Osborne D; Alexander GE; Boeve BF
    Sleep; 2002 Jun; 25(4):447-53. PubMed ID: 12071547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.